Botswana · Medical and donor conditions

Consultation desk with medical records and a microscope in a laboratory behind glass; editorial illustration.
Editorial illustration only; it does not depict a verified clinic, approval or real patient.

Botswana: medical and gamete-donor requirements

Short answer: Botswana’s general public-health legislation addresses the removal, use and payment-related aspects of human gametes, but the sources do not establish a comprehensive, assisted-reproduction-specific code setting donor eligibility, testing schedules or IVF and embryo-handling rules. A provider should not present its own protocol as a statutory requirement, and legal silence should not be treated as proof that a procedure is permitted. The main starting point is the Public Health Act (Cap. 63:01), especially sections 160, 161 and 165. The WHO CPCD repository provides a copy of the 2013 Act, but it is not an official consolidated register; confirm the current official text, commencement status and subsidiary legislation before relying on it.

What the available law establishes — and what it does not

This guide addresses medical and gamete-donor questions in Botswana. It does not determine whether a surrogacy agreement is valid, who will be a child’s legal parent, or whether a child can obtain nationality or travel documents. The Government of Botswana directs users to its e-Laws service for current legislation. A report dated 2 February 2026 quoted the Attorney General’s Chambers as saying Botswana had no specific surrogacy framework, but that is secondary reporting, not a substitute for a current official-law search. The careful conclusion is therefore limited: no comprehensive ART or donor-specific framework was identified in the accessible materials.

Permitted use and the under-18 restriction

Section 161(1) provides that, unless otherwise prescribed, tissue, blood or gametes removed from a living person may be used only for medical or dental purposes. Section 161(2)(c) restricts the use, for purposes contemplated by section 169, of a gamete removed from a person younger than 18. Section 169 lists medical and dental training, research and therapeutic purposes. Where donated gametes are proposed for therapeutic fertility treatment, the under-18 restriction is a material issue and should be treated as a stop-and-confirm point. The precise application of this statutory scheme to a particular assisted-reproduction procedure, and any later amendments or regulations, should be confirmed against the official current text.

Mental-health wording: a point for legal confirmation

Section 161(2)(a) also refers to tissue, blood or gametes of a person who is “mentally ill” within the meaning of the Mental Disorders Act, for purposes contemplated by section 169. The provision’s wording and its application to gamete donation for fertility treatment require local legal interpretation. Do not convert this statutory term into an informal diagnosis or assume that it replaces a clinical assessment of decision-making capacity. Before a clinic accepts or excludes a donor on this basis, ask a Botswana-qualified lawyer or the competent health authority to confirm the provision’s current meaning, scope and application.

Donor compensation, expenses and clinic fees

Section 165(3) states that a person who receives any financial reward for donating tissue, gametes or blood commits an offence, except for reimbursement of costs incurred in providing the donation. Do not describe a fixed profit or unexplained lump sum as “expenses” without a defensible basis and supporting records. Section 165(1)(a) restricts who may receive payments connected with importing, acquiring or supplying tissue or gametes; it identifies persons or institutions referred to in section 159, authorised institutions and, where tissue or gametes are imported under the regulations, the importer concerned. The subsection refers to purposes in sections 161 or 175, but the consulted text labels section 175 “Powers of entry and inspection”, so that cross-reference is unclear and must be checked against the current official text and local legal interpretation before relying on the payment rule. A general facility or practitioner licence alone does not establish that a recipient falls within a category permitted to receive the particular payment under section 165(1). Ask the clinic to identify the exact statutory category it relies on and provide any relevant designation or authorisation, explaining how it applies to gametes. Section 165(2) preserves remuneration for professional services by registered medical or dental practitioners. A professional fee is therefore a different category from payment for the gamete itself. Review clinic fees, intermediary charges, donor reimbursements and import costs separately; do not assume that one permitted payment makes every other payment lawful.

Clinic and practitioner authorisation

Botswana’s Ministry of Health and Wellness states that private health facilities and practitioners are subject to licensing and regulatory oversight, and that health professionals are registered through the relevant professional councils. Before treatment, verify the facility’s current licence and the registration and practising status of each clinician responsible for collection, laboratory work and treatment. Ask where the laboratory is located and who is responsible for gamete storage and traceability. General facility or practitioner licensing does not, by itself, prove that a particular donor programme or every assisted-reproduction technique has a separate ART approval. Request the actual licence details and written confirmation of the scope of authorised services.

Donor screening: do not mistake clinic policy for legislation

No current, binding Botswana-wide donor protocol has been published specifying all screening tests, genetic assessment, psychological counselling, donor anonymity, donor-number limits, adult-donor age bands, storage periods, consent withdrawal rules or embryo-disposition procedures for IVF. Do not tell patients that these matters are “not regulated at all” without checking the current regulations, professional standards, licence conditions and official guidance. Equally, do not present a clinic’s internal checklist as legislation unless the clinic can identify the provision or binding instrument that makes it compulsory. The Act also contains section 106 on HIV testing of tissue donors: it requires a test immediately before donation and a negative test on the tissue immediately before use. The provision says “tissue” rather than expressly saying “gametes”; its application to gamete donation must be confirmed. Do not assume that it either definitely applies or definitely does not apply to gametes.

Clinical safeguards to request

Even where a specific legal screening schedule has not been verified, a careful clinical programme should explain its medical safeguards before obtaining consent or money. Ask the treating clinician to describe which infectious-disease tests, medical and family-history review, genetic-risk assessment, counselling and laboratory checks are clinically indicated for the proposed treatment. The clinic should also explain sample identification, chain of custody, storage conditions, access to records, privacy, disclosure of significant findings, and the risks and limits of testing. These are practical risk-control requests, not a statement that each item is expressly mandated by Botswana statute. Clinical decisions should be made by qualified professionals for the individual case.

Practical decision matrix

Use the matrix as a triage tool, not a substitute for current law. “Text located” means the provision appears in the consolidation consulted; it does not settle its application to every ART scenario. “Not verified” means no specific rule was established in accessible materials. Ask the clinic to identify the binding source for every mandatory requirement, and seek local legal advice where scope is uncertain.

IssueStatusPractical meaning
Written consentExpress provision locatedSection 160 refers to written consent and prescribed conditions; confirm the current prescribed procedure.
Gametes from a person under 18Conditional statutory restrictionSection 161(2)(c), read with section 169, is a stop-and-confirm issue for therapeutic use.
Mental-health wordingStatutory text located; scope needs interpretationSection 161(2)(a) uses a defined legal term; do not apply it as an informal diagnosis.
Donor reward and supply/import paymentsDonor reward is prohibited except for costs; recipient categories and cross-reference need checkingSection 165(3) permits reimbursement of costs incurred, not assumed profit. Section 165(1)(a) lists recipient categories but refers to section 175, whose heading in the consulted text is “Powers of entry and inspection”; verify the cross-reference and recipient status before relying on it.
Donor screening scheduleNo published ruleRequest the clinic’s written protocol and its legal or professional basis.
Clinic/practitioner licensingGeneral oversight confirmed by the MinistryVerify the actual licence and practising status; this is not proof of ART-specific approval.
Import/export and surrogacy statusSeparate confirmation requiredCheck both jurisdictions and analyse parentage and travel independently.
HIV testing of tissue donorsExpress rule for tissue; gamete scope unresolvedSection 106 requires a test before tissue donation and a negative tissue test before use; confirm whether it covers gametes.

Steps to take before treatment or payment

Before treatment, ask the clinic and your lawyer to complete these checks in writing:

  1. Request the current official Act and all applicable regulations or statutory instruments from the official Botswana legal source.
  2. Ask for a written legal basis for every donor eligibility criterion and every test said to be legally mandatory.
  3. Check the current facility licence and each responsible practitioner’s registration and practising status.
  4. Read the donor consent before collection, including intended use, storage, transfer, disclosure and future-use terms.
  5. Obtain the clinic’s dated medical-screening, laboratory, identification and traceability protocol.
  6. Separate donor cost reimbursement from professional fees, intermediary charges and import or transport costs; for any payment covered by section 165(1), ask the recipient to identify the statutory category it relies on and provide any relevant supporting designation or authorisation.
  7. For cross-border material or a surrogate arrangement, get written advice and authority confirmation before payment, collection or transfer.

Questions to put to the clinic in writing

Ask the clinic to answer the following questions in writing and identify the responsible person and legal source:

  • Which exact statutory provision, regulation, professional standard or licence condition requires this step?
  • Who is authorised and responsible for collection, laboratory handling, storage and traceability?
  • Which payments are donor-cost reimbursements, professional fees, intermediary charges or import/supply payments; who receives each, what records support them, and, for payments covered by section 165(1), which statutory category permits the recipient to receive them?
  • What does the donor consent cover, and how are withdrawal, storage, future use and disclosure handled?
  • Who holds the records, what privacy safeguards apply, and how long will the records be retained?
  • Which authority has confirmed the import, export or transport requirements for gametes or embryos?

Warning signs

Pause and seek independent advice if any of the following warning signs appear:

  • “It is legal” without a current provision, licence or written answer.
  • A request for donor “expenses” with no itemisation or evidence of costs incurred.
  • No signed consent or no explanation of storage, future use, transfer and disclosure.
  • No verifiable facility or practitioner credentials, or unclear responsibility for the laboratory.
  • A claim that a clinic licence automatically approves every donor or surrogacy arrangement.
  • A promise that IVF or a surrogacy contract guarantees parentage, nationality or a travel document.

Surrogacy and cross-border treatment are separate questions

Gamete-donor rules do not settle the separate legal questions raised by surrogacy. A plan involving a surrogate, embryos created in another country, or treatment across borders requires separate analysis of the law where the donor is collected from, where laboratory work and embryo transfer occur, where the child is born, and where the intended parents live. Confirm import and export requirements for gametes or embryos with the relevant authorities before moving material. Also obtain separate advice on the surrogacy agreement, legal parentage, birth registration, nationality, travel documents and recognition in the destination country. Do not infer that permission for a medical procedure automatically validates a surrogacy agreement or guarantees the child’s status.

Records to keep

Keep the records listed below in an organised file. Protect health data and share it only with people who need it. These records may help establish what was agreed, checked, stored and paid if a dispute arises.

  • Signed and dated consent forms, including later amendments or withdrawal notices.
  • Available donor screening and eligibility records, with test dates and responsible clinician.
  • Sample identifiers, laboratory handling, storage, transfer and disposal records.
  • Current facility and practitioner licence details and any written scope-of-service confirmation.
  • Itemised invoices and evidence supporting reimbursed donor expenses.
  • Written advice from Botswana counsel and written responses or permits from competent authorities.

Bottom line

The safest current approach is to treat sections 160, 161 and 165 of the Public Health Act as important starting points, not as a complete ART code. Written consent, the conditional under-18 restriction and the rule against donor financial reward beyond reimbursement of incurred costs require careful attention, subject to confirmation against the official current law and its application. Donor testing schedules and other operational details must be supported by an identified binding rule or clearly labelled as clinical policy. Do not pay, collect or transfer gametes on the strength of marketing claims alone. Obtain written clinic answers and Botswana-specific legal review before making an irreversible decision.

Sources and verification limits

  1. S1. Government of Botswana — Access to Laws of Botswana — Official government directory for accessing current legislation and judgments.
  2. S2. Public Health Act 2013 — copy hosted in the WHO CPCD repository — WHO CPCD hosts a copy of the 2013 Act and labels its database updated 18 April 2025, but warns that it may not reflect the latest law; verify the current official text.
  3. S3. Botswana Ministry of Health and Wellness — Regulatory Services — Official ministry page on general health-facility and practitioner regulation; not ART-specific approval.
  4. S4. Gender Links, “Botswana: Legal void on surrogacy” (2 February 2026; secondary report) — Secondary report dated 2 February 2026; not primary legislation or an official consolidated text.
  5. S5. FAOLEX — Public Health Act (Chapter 63:01) — Publicly accessible reproduction of the Act; it independently confirms the text of sections 106, 160, 161 and 165, including the reference to section 175. FAOLEX is not Botswana’s official consolidated register and does not establish current amendment status.

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards